Molecular Virology Lead Technician

Cape Fox subsidiary Eagle Health, LLC is accepting resumes for a Molecular Virology Lead Technicianto support the members at Ft. Detrick, Maryland. This position is contingent upon contract award.

Incumbents are encouraged to apply!

The salary range (or hiring range) for this exempt position has been established at: $85,000 - $95,000.

The above salary range represents the company's good faith and reasonable estimate of the range of possible compensation at the time of posting. In addition, we offer a variety of benefits including company holidays, paid time off, health insurance, dental insurance, vision insurance, life and disability insurance, tuition reimbursement, as well as 401K with company match. This job will be posted until filled or withdrawn.

Responsibilities:

• The employee shall provide support with laboratory experiments in BSL-2, BSL-3 and BSL-4 laboratories and thus must hold and maintain BPRP status, IAW the provisions in this contract and applicable regulations.
• The employee will work with controlled substances and therefore must hold and maintain CS-PRP status, IAW the provisions of this contract and applicable regulations.
• The employee shall aid in the execution of scientific studies, basic cell culture, and plaque assays, polymerase chain reaction (PCR) and other assays, animal procedures, collection/data analyzing, assist in the preparation of technical reports, standard operating procedures, and manuscripts relating to their research efforts, and maintain laboratory and laboratory equipment.
• Serve as BSL-3 and/or BSL-4 mentor as needed.
• CONUS/OCONUS travel may be required in support of approved studies and/or presentation of scientific research.
• Prepare and participate in BSL-2 and BSL-3 laboratory inspections conducted by Safety, Bio- surety, CDC, and/or the Department of Army Inspector General at a minimum of 4 times a year.
• Will support 20-25 Non-human Primate studies, 40-50 rodent studies per year. Will perform inoculations with virus, collecting tissue for processing and conduct bleedings. Will perform Complete Blood Count (CBC), general chemistries, coagulation assays and other clinical laboratory based assays on samples from animals.
• Will perform basic cell culture, plaque assays (PA), plaque reduction neutralization test (PRNT), PCR and other assays to support Non-human Primate and rodent studies. Will be proficient at completing neutralization assay for a variety of viruses. Workload is approximately 650 plates/assays per month.
• Will perform in vitro testing of candidate vaccines and therapeutic compounds against a variety of viruses. May use 100-200 plates/assays per month.
• Will perform immunological procedures including enzyme-linked immunosorbent assay (ELISA) and Western Blot assays. May perform 150 assays/month.
• Will be proficient at completing flow cytometric analysis of cellular populations independently on multiple different flow cytometry machines in BSL-3 and BSL-4 laboratories. Will perform approximately 100 tubes/samples per month.
• Will be responsible for assessing and maintaining laboratory supplies in BSL-2, BSL-3 and BSL-4 laboratories. Will assess supplies and ensure supplies are ordered or will order supplies using GFEBS and/or DMLSS ordering system. Anticipated workload is 15-20 orders/monthly.
• Provide the TPOC a Research Technical Report NLT the last day of each week.
• CS-PRP enrollment is required and will be held and maintained IAW the provisions in this contract and all applicable regulations.
• BPRP enrollment is required and will be held and maintained IAW the provisions in this contract and all applicable regulations.

Cape Fox Corporation, its subsidiaries and affiliates provide equal employment opportunities to all persons and prohibit employment decisions on the basis of race, religion, color, creed, national origin, sex, age, disability, political affiliation, protected veteran status, or sexual orientation. Cape Fox Corporation, its subsidiaries and affiliates offer preference to Cape Fox Corporation shareholders, descendants and other Native Americans pursuant to Public Law 100-241.